We are live on ! Find out more
H

HoyleCohen Portfolio holdings

AUM $1.32B
1-Year Est. Return 27.05%
This Fund
S&P 500
This Quarter Est. Return
+5.88%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
AUM
$984M
AUM Growth
+$117M
Cap. Flow
+$5.06M
Cap. Flow %
0.51%
Top 10 Hldgs %
30.99%
Holding
268
New
45
Increased
118
Reduced
70
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 23.15%
2 Financials 11.49%
3 Healthcare 9.7%
4 Communication Services 8.7%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
251
iShares Select Dividend ETF
DVY
$24B
$214K 0.02%
+1,877
New +$198K
SDY icon
252
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$210K 0.02%
+1,780
New +$200K
VFH icon
253
Vanguard Financials ETF
VFH
$13.3B
$210K 0.02%
+2,490
New +$199K
XLRE icon
254
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.69B
$209K 0.02%
+5,304
New +$199K
MU icon
255
Micron Technology
MU
$1.04T
$207K 0.02%
+2,350
New +$199K
DAL icon
256
Delta Air Lines
DAL
$55.9B
$206K 0.02%
+4,261
New +$189K
FRC
257
DELISTED
First Republic Bank
FRC
$202K 0.02%
+1,209
New +$196K
SHOP icon
258
Shopify
SHOP
$148B
$201K 0.02%
+1,820
New +$220K
ET icon
259
Energy Transfer Partners
ET
$70.1B
$174K 0.02%
22,682
-21,651
-49% -$158K
F icon
260
Ford
F
$57.3B
$147K 0.01%
11,976
+600
+5% +$6.87K
VIRX
261
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$130K 0.01%
+14,000
New +$146K
NUV icon
262
Nuveen Municipal Value Fund
NUV
$1.91B
$117K 0.01%
+10,500
New +$117K
TCON
263
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$107K 0.01%
650
AMRN
264
Amarin Corp
AMRN
$284M
$93K 0.01%
750
-550
-42% -$74K
PPT
265
Franklin Premier Income Trust
PPT
$323M
$87K 0.01%
17,900
SMMT icon
266
Summit Therapeutics
SMMT
$10.9B
$61K 0.01%
10,359
AMPE
267
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$17K ﹤0.01%
+33
New +$17K
TKC icon
268
Turkcell
TKC
$4.84B
-17,290
Closed -$93K

Similar funds

HoyleCohen's Q1 2021 Portfolio in Review

As of Q1 2021, HoyleCohen held 268 positions worth $984M, up 14% from $867M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HoyleCohen's Q1 2021 filing shows 45 new, 118 increased, 70 reduced and 1 closed positions. Its largest new stake was Thermo Fisher Scientific: 12,995 shares worth $5.93M. The largest sale was Berkshire Hathaway Class A, an estimated $72.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • HoyleCohen's largest Q1 2021 buy was Thermo Fisher Scientific: 12,995 shares worth $5.93M.
  • HoyleCohen added most to Schwab U.S Small- Cap ETF in Q1 2021, an estimated $19.9M increase.
  • HoyleCohen's biggest Q1 2021 reduction was Berkshire Hathaway Class A, cutting an estimated $72.6M.
  • HoyleCohen fully exited Turkcell in Q1 2021, selling an estimated $93K.
  • HoyleCohen's ten largest holdings make up 31% of its $984M portfolio in Q1 2021.
  • HoyleCohen opened 45 new positions and closed 1 in Q1 2021.
  • HoyleCohen's portfolio value rose 14% quarter-over-quarter to $984M.

Based on HoyleCohen's 13F filing for Q1 2021, filed 14 May 2021.